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Abstract – Transthyretin (TTR) is a serum protein which is a negative acute phase reactant in
humans and levels of TTR are routinely measured as an indicator of health status. Such tests have
yet to be established for the pig. In order to measure serum TTR in the pig during an acute phase
response an assay was developed using anti-human TTR antibodies which cross reacted with
porcine TTR. The assay had a detection limit of 32 µg/mL while the mean concentration of
transthyretin measured in healthy pig serum was 302 ± 8 µg/mL (n = 63). There was no significant
difference in the serum concentration of TTR in three different age groups from 10 to 25 weeks.
Following Streptococcus suis type 2 infection transthyretin showed a negative acute phase response
with serum concentrations reaching a significantly lower level at two days following infection.
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1. INTRODUCTION
Acute phase proteins (APP) are blood
proteins, which alter concentration dramat-
ically following infection, inflammation
and trauma [10]. The serum level of these
proteins either increases in the case of pos-
itive acute phase proteins such as hap-
toglobin, C-reactive protein and serum
amyloid A [5] or decreases in the case of
negative acute phase proteins such as tran-
sthyretin (TTR) [13, 14]. The level of pos-
itive APP in porcine sera has been shown to
provide an objective measure of animal
health status and is becoming widely used
as a gauge of animal welfare which is
understood as freedom of disease and, to a
certain extent stress [8, 12, 17–19, 21]. In
addition, concentration of the positive acute
phase proteins has been shown to be pro-
portional to the severity of the condition so
they can be used both to monitor the pres-
ence and extent of a disease in pigs [3, 7]
and may also be used to measure the effi-
cacy of antibiotic treatment [12, 15, 16]. In
human medicine the CRP/TTR ratio has
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been used for the early diagnosis of post
operative bacterial infection [9]. Monitor-
ing the levels of negative acute phase reac-
tants in porcine sera in addition to the pos-
itive ones should bring additional value to
these measurements, for example by con-
stituting an internal control for dilution and
evaporation artefacts. 
TTR, also known as thyroxin-binding
prealbumin, is a serum protein with a
molecular mass of ~ 55 kDa made up of four
identical subunits. It is one of the three
major thyroxin binding proteins and forms
a complex with retinol binding protein to
aid the transport of vitamin A in plasma [14,
20]. The porcine isoform shares 85%
sequence homology with the human form
but has three additional amino acids at the
C-terminus (Gly-Ala-Leu) giving it a sub-
unit length of 130 amino acids [2, 6]. In man
TTR serum levels fall due to decreased syn-
thesis in inflammation and stress [13].
Human serum levels of TTR have been
measured for hospital patients as an indica-
tor of health status [4, 11, 22] and a number
of commercial assays are available for this
purpose. However, whether transthyretin is
indeed a negative acute phase reactant has
yet to be established for the pig. Therefore
the aim of this study was to develop and val-
idate an assay to measure TTR in porcine
serum and to use this assay to determine
whether TTR levels in porcine sera fall dur-
ing an acute phase response. An enzyme
linked immuno sorbent assay (ELISA) was
established for this purpose using an antise-
rum to human TTR. The specificity of this
antiserum for porcine TTR was confirmed
by western blotting.
2. MATERIALS AND METHODS
2.1. Animals and collection of samples
Blood samples were collected from two
different groups of animals. The first group
was made up of 63 conventionally housed
healthy pigs. Animals were defined as
healthy on the basis of a clinical examina-
tion in the herd by a trained technician look-
ing at the moving animal and at the immo-
bilised animal that was palpated (limbs and
umbilicus). Three pigs from each of three
age groups, 10–14, 15–19 and 20–25 weeks
from each of 7 different herds were used.
Additional blood samples were collected
from a second group of five pigs (approx.
6 weeks of age at time of infection) from
days –8, 0, 1, 2, 5, 8, 12 and 14 after infec-
tion with a Streptococcus suis type 2 isolate.
The experimental animals were infected by
subcutaneous injection of approx. 1011 CFU
of S. suis strain SS02-0119 as previously
described [1]. Blood was allowed to clot
and serum aspirated and stored at –20 °C
until analysed. Establishment of infection
was confirmed in all five pigs by culture of
S. suis type 2 from blood samples on day 1
and 8 post inoculation (p.i.). The pigs were
monitored by recording clinical signs of
disease and body temperature daily through-
out the experiment. Four of the five pigs
developed transient signs of arthritis during
days 2–7 p.i. Arthritis was confirmed by
histopathological examination. These four
pigs also developed fever, defined as a rise
in temperature ≥ 40 °C. One pig did not
develop any clinical signs of disease or
fever. All animal experiments were per-
formed in accordance with a licence from
the Danish Animal Experiments Inspector-
ate.
2.2. Two dimensional gel electrophoresis
Porcine serum was prepared in rehydra-
tion buffer (8 M urea, 2% w/v CHAPS,
0.5% Biolyte 3–10 IPG Buffer and 2.8 %
w/v dithiothreitol) at a protein concentra-
tion of 1 mg/mL. The sample (125 µL) was
then applied to 7 cm immobilised pH gra-
dient gel (IPG) ready strip pH 3–10 (Bio-
Rad, Hemel Hemsted, UK) which was then
rehydrated in a Bio-Rad Protean IEF cell for
600 VHrs followed by isoelectric focusing
for 24 000 VHrs.
Immediately following IEF the strip was
equilibrated with 6 M urea, 0.375 M Tris
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pH 8.8, 1% v/w, SDS, 20% (v/v) glycerol
and 2% (w/v) dithiothreitol for 10 min and
then for a further 10 min in the same buffer
with the dithiothreitol replaced by 2.5% (w/v)
iodoacetamide. After equilibration the strip
was applied to a 15% polyacryamide gel
which was run on Bio-Rad Mini Protean
3 system according to the manufacturer’s
instructions. Gels were then stained with
Coomassie Brilliant Blue R-250. 
2.3. Immunoblotting
Proteins were transferred from acryla-
mide gels onto nitrocellulose membranes at
100 V for 1 h using the mini Trans-Blot Cell
(Bio-Rad, Hemel Hempsted, UK). Transfer
buffer was 25 mM Tris, 192 mM glycine,
pH 8.3, 20% (v/v) methanol. Following
protein transfer the membranes were
blocked with 5% (w/v) non fat dry milk,
0.1% Tween-20 in Tris buffered saline
(TBS), (100 mM Tris–HCl, 150 mM NaCl)
pH 7.4 (TTBS). The membranes were then
incubated for 1 h with sheep anti-human
prealbumin (TTR) (IgG fraction) (ICN Bio-
medicals, Basingstoke UK) diluted 1/1000
in TTBS containing 0.5% non fat dried
milk, washed with TTBS and then incu-
bated with HRP conjugated anti-sheep IgG
(Sigma, Poole, UK) 1:2000 in TTBS for
30 min. The membrane was washed with
TTBS three times and then developed using
the Opti-4CN Substrate Kit (Bio-Rad,
Hemel Hempsted, UK).
2.4. Mass spectrometry
Mass spectrometry (MS) was carried out
at The Sir Henry Wellcome Functional
Genomics Facility at The University of
Glasgow. Spots from Coomassie Blue
stained gels were excised and subjected to
digestion with trypsin. Extracted peptides
were desalted manually (ZipTip tips, Mill-
ipore, UK) before using Q-Star Pulsar™
LC/MS/MS (Applied Biosystems, UK) for
sequence analysis of the peptides. The
resulting MS/MS data were then searched
in-house using Mascot™ software (http://
www.matrixscience.com/) equipped with
translated databases for protein identifica-
tion.
2.5. Confirmation of antibody specificity
To confirm the specificity of the sheep
anti-human prealbumin raised to human
TTR it was tested for cross reactivity with
porcine TTR. Porcine serum was run on 2D
PAGE and the resulting gel stained with
Coomassie Blue (Fig. 1A) an identical gel
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Figure 1. (A) 2-Dimensional electrophoresis gel of porcine serum stained with Coomasie Brilliant
Blue. (B) Immunoblot of 2DE gel showing crossreactivity with sheep anti-human prealbumin anti-
serum.
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was run and transferred to nitrocellulose,
immuno blotting was carried out using anti
human TTR (Fig. 1B). The protein spot on
the Coomassie Blue stained gel which
showed cross reactivity with anti TTR was
cut from the gel and confirmed as porcine
transthyretin after MS of the peptides gen-
erated following digestion by trypsin. The
MS fingerprint data was examined using
Mascot™, MS/MS Ions Search Analysis
and showed protein identity matches to
accession number gi|47523508 (similar to
transthyretin (prealbumin), amyloidosis type
I) [Sus scrofa] and to accession number
gi|975233 (putative transthyretin (prealbu-
min) [Sus scrofa] [6]. The antibody was
therefore specific for porcine transthyretin
and could be used to measure transthyretin
levels in porcine sera. 
2.6. TTR assay development
Microtiterplates (96 well, Corning Cos-
tar, Cambridge UK) were coated with serum
samples or purified human prealbumin
(TTR) (Sigma-Aldrich, Poole, UK) diluted
in 50 mM NaHCO3 (pH 9.6), 100 µL/well
for 20 hours at 4 oC. The samples were then
decanted and unbound sites blocked by
adding 250 µL of 5% (w/v) non fat dried
milk in assay buffer, (0.12 M NaCl, 0.02 M
Na2HPO4, 0.1% (v/v) Tween 20, pH 7.4) at
room temperature for 30 min. The plates
were washed with assay buffer and then
100 µL of sheep anti-human TTR diluted
1/1000 in assay buffer was added to each
well and the plates incubated for 1 h at 37 °C.
The wells were then decanted and washed
three times in assay buffer. Then 100 µL of
HRP conjugated anti-sheep IgG (Sigma,
Poole, UK) 1:2000 in assay buffer was
added to each well and incubated for 30 min
at 37 °C. After washing three times with
assay buffer the wells were filled with
100 µL freshly prepared TMB substrate
solution (KPL, Guildford, UK) the reaction
was stopped after 30 min by the addition of
50 µL of 1 M HCl and then the absorbance
was read at 450 nm. The TTR concentration
in the serum samples after a 1:400 dilution
was compared to a standard curve of human
TTR over a range of 0.03–2.00 µg/mL.
Detection limits were determined by meas-
uring 15 replicates of saline and replicates
of the lowest concentration standard and
calculating the mean concentration of
saline +2 SD of the lowest concentration
using human TTR as standard.
2.7. Acute phase protein measurements
Serum amyloid A (SAA) in porcine
serum was assayed using the Phase SAA
Assay kit (Tridelta Development plc, Ireland)
according to the manufacturer’s instructions. 
2.8. Statistical analysis
Data are expressed as means ± SEM.
Comparisons were performed using paired
t-test. Significance was set at P < 0.05. 
3. RESULTS
Initially a standard curve was estab-
lished by binding increasing amounts of
purified human TTR to a microtitre plate.
Figure 2A shows a representative standard
curve and parallel curve for doubling dilu-
tions of pooled porcine sera starting with a
1 in 400 dilution. The lower detection limit
for porcine serum TTR (1:1000 dilution)
was determined as 0.032 µg/mL. Linearity
under dilution was demonstrated by a plot
of measured versus calculated values of
TTR in porcine serum which had a regres-
sion line with equation y = 1.0269x + 3.543
and a correlation coefficient of 0.997. The
interassay precision determined by calcula-
tion of coefficient of variance (CV) of 8.4 %
at 129.4 µg/mL and 13.8% at 83.6 µg/mL
was obtained by measuring the same two
porcine serum samples in 18 separate
assays. The intraassay CV was ascertained
to be 2.2 % being the mean of the CVs of
28 duplicate samples in the same assay at a
concentration range of 117–292 µg/mL.
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Serum samples taken from individual
healthy pigs, in three different age groups
(n = 21 per group) were assayed for TTR
(Fig. 3) and showed there were no differ-
ences in TTR concentrations between the
age groups. The mean value for all of the
samples was 302 ± 8 µg/mL (n = 63). In
order to assess the acute phase reaction of
transthyretin in pigs following infection
TTR was measured in serum samples from
five pigs at time intervals following infec-
tion with a S. suis type 2, ribotype I isolate
administered by subcutaneous injection.
These samples were tested in duplicate in
the same analytical run. The mean values
for all five pigs at each time interval is
shown in Figure 4. A drop in transthyretin
levels was observed with the mean TTR
concentration falling to 81% of preinfec-
tion concentration by day 2 following injec-
tion. This fall was found to be significantly
different (P = 0.004 two tailed paired t test)
Figure 2. Mean standard curve of purified human TTR (n = 18) compared to doubling dilutions of
porcine serum starting with a 1 in 400 dilution.
Figure 3. Serum transthyretin concentrations in samples from healthy pigs, 63 conventionally
housed pigs (3 pigs from each of three age groups from each of 7 different herds).
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from the values prior to infection (day 0).
The serum level of the positive acute phase
protein SAA was also measured in these
samples (Fig. 5) and serum levels of SAA
increased significantly by day 1 and day 2
reaching a mean value of 232 ± 34.8 µg/mL
following infection before returning to base
line levels.
4. DISCUSSION
For the first time a method to measure the
levels of transthyretin in porcine serum has
been developed which shows that TTR is a
negative acute phase reactant in pig.
 Immunoblotting and mass spectrometry
demonstrated that commercially available
sheep polyclonal antiserum raised to human
transthyretin cross reacted with porcine TTR.
This cross reactivity is probably due to the
85% amino acid sequence homology between
porcine and human transthyretin protein
sequences and the lack of glycosylation of
TTR [14, 20]. The specific antibody was
used to develop an assay for measuring
transthyretin in pig serum. Accuracy of the
assay was demonstrated by the parallel
curve obtained by serial dilution of a por-
cine serum sample compared to the stand-
ard curve. The CV calculations (< 130 µg/mL)
fall below the normal range (300 µg/mL)
and the range during S. suis infection
(> 200 µg/mL) and it is possible that the
inter-assay CV may increase with increas-
ing concentrations of transthyretin. How-
ever, no significant differences were found
in values obtained from repeat assays of
samples containing > 250 µg/mL of TTR.
Using this assay TTR in porcine sera can be
measured in a consistent and reproducible
manner with acceptable precision.
 Following S. suis infection transthyretin
showed a negative acute phase response
with serum levels falling significantly two
days following treatment then returning to
pretreatment values after 5 days. In contrast
serum levels of SAA which is an estab-
lished acute phase indicator in pigs [12]
rose one day after infection, remained high
for two days and then fell back to baseline
levels after 5 days. The fall in levels of TTR
during the acute phase response was rela-
tively small compared to the increases
found in SAA which increased by 39 fold.
However, it is consistent with drops in
human transthyretin levels following infec-
tion reported previously [9].
The assay we have developed for TTR
may have the disadvantage of relying on
passively adsorbing the antigen to a surface
in competition with all the other serum
Figure 4. Transthyretin concentrations in pigs
after infection (s.c. injection) with a S. suis type 2,
ribotype I isolate. Samples from five pigs
(approx. 6 weeks of age at time of infection)
from days –8, 0, 1, 2, 5, 8, 12 and 14. * P < 0.05
compared to day 0.
Figure 5. SAA concentrations after infection
(s.c. injection) with a S. suis type 2, ribotype I
isolate. Samples from five pigs (approx. 6 weeks
of age at time of infection) from days –8, 0, 1,
2, 5, 8, 12 and 14. * P < 0.05 compared to day 0.
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proteins. This, on the other hand may be less
of a drawback considering that TTR con-
centrations vary only slightly. However the
detection limit might be lowered signifi-
cantly by using a sandwich ELISA with
antibodies raised to purified porcine tran-
sthyretin to trap the TTR. 
It is possible therefore that porcine TTR
could be a valuable negative acute phase
protein for monitoring the health of pigs.
Indeed even if the acute phase change of
TTR in pigs adds only marginally to the
diagnostic information on the acute phase
its measurement may be more useful for
monitoring nutritional or growth related
phenomena as it is in man [14]. 
In conclusion we have developed a
means to measure TTR in pig serum and
demonstrated that the concentration of this
protein in serum falls in response to S. suis
type 2 infection. Measuring the levels of
TTR in serum in addition to other acute
phase proteins to monitor pig health status
may provide extra information and war-
rants further investigation.
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